Data / Form D filings / QUINCY BIOSCIENCE HOLDING CO INC
QUINCY BIOSCIENCE HOLDING CO INC: Form D filings
QUINCY BIOSCIENCE HOLDING CO INC, a pharmaceuticals company in Madison, WI, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on December 15, 2010, reports $5.2 million sold of a $6.5 million offering to 89 investors.
Find out what QUINCY BIOSCIENCE HOLDING CO INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 301 SOUTH WESTFIELD ROAD, SUITE 200, Madison, WI, 53717
- Phone
- (877) 677-8652
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Wisconsin
- Year incorporated
- 2005
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1377795
The full lists. Form D filings in Wisconsin: 361 rows, $18.05, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 15, 2010 | Amendment | $6,500,000 | $5,181,090 | $1,318,910 | 89 | May 15, 2009 | sec.gov |
| Jun 1, 2009 | New notice | $7,365,000 | $10,000 | $7,355,000 | 1 | May 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Y. Flemming | Director | |
| Michael J. Beaman | Executive Officer, Director | |
| Robert C. Risch, Jr. | Executive Officer, Director | |
| Mark Y. Underwood | Executive Officer, Director | |
| Robert Y. Moser | Director | |
| John Y. Dedrick | Director |
Every Form D from the week of Dec 13, 2010 · All recent filings in Wisconsin · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what QUINCY BIOSCIENCE HOLDING CO INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.